An Approach towards in Management of Chronic Kidney Disease
Abstract
Keywords
Full Text:
PDFReferences
Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017; 389(10075): 1238–1252p. doi:10.1016/S0140-6736(16)32064-5
Wühl E, Schaefer F. Therapeutic Strategies to Slow Chronic Kidney Disease Progression. Pediatr Nephrol. 2008; 23(5): 705–716p. doi:10.1007/s00467-008-0789-y
Van Rensburg B, Meyer AM. Clinical Aspects of Chronic Kidney Disease. South African Med J. 2015; 105(3): 237p. doi:10.7196/SAMJ.9413.
Bakris GL, Williams M, Dworkin L, et al. Preserving Renal Function in Adults with Hypertension and Diabetes: A Consensus Approach. Am J Kidney Dis. 2000; 36(3): 646–661p. doi:10.1053/ajkd.2000.16225
JCP, SA, JMB, et al. Blood Pressure Control, Proteinuria, and the Progression of Renal Disease: The Modification of Diet in Renal Disease Study. Ann Intern Med. 1995; 123(10): 754–762p.
Abecassis M, Bartlett ST, Collins AJ, et al. Kidney Transplantation as Primary Therapy for End-Stage Renal Disease: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) Conference. Clin J Am Soc Nephrol. 2008; 3(2): 471–480p. doi:10.2215/CJN.05021107
Jacob P, Hartung R, Bohlender J, Stein G. Utility of 24-h Ambulatory Blood Pressure Measurement in a Routine Clinical Setting of Patients with Chronic Renal Disease. J Hum Hypertens. 2004; 18(10): 745–751p. doi:10.1038/sj.jhh.1001734
Risdon RA, Sloper JC, De Wardener HE. Relationship between Renal Function and Histological Changes Found in Renal-Biopsy Specimens from Patients with Persistent Glomerular Nephritis. Lancet. 1968; 2(7564): 363–366p. doi:10.1016/s0140-6736(68)90589-8
Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma Lipids and Risk of Developing Renal Dysfunction: The Atherosclerosis Risk in Communities Study. Kidney Int. 2000; 58(1): 293–301p. doi:10.1046/j.1523-1755.2000.00165.x
Abrass CK. Cellular Lipid Metabolism and the Role of Lipids in Progressive Renal Disease. Am J Nephrol. 2004; 24(1): 46–53p. doi:10.1159/000075925
Kang DH, Kanellis J, Hugo C, et al. Role of the Microvascular Endothelium in Progressive Renal Disease. J Am Soc Nephrol. 2002; 13(3): 806–816p.
Orphanides C, Fine LG, Norman JT. Hypoxia Stimulates Proximal Tubular Cell Matrix Production via a TGF-β1-Independent Mechanism. Kidney Int. 1997; 52(3): 637–647p. doi:10.1038/ki.1997.377
Karamouzis I, Sarafidis PA, Karamouzis M, et al. Increase in Oxidative Stress but not in Antioxidant Capacity with Advancing Stages of Chronic Kidney Disease. Am J Nephrol. 2008; 28(3): 397–404p. doi:10.1159/000112413
Brunelli SM, Lewis JD, Gupta M, Latif SM, Weiner MG, Feldman HI. Risk of Kidney Injury Following Oral Phosphosoda Bowel Preparations. J Am Soc Nephrol. 2007; 18(12): 3199–3205p. doi:10.1681/ASN.2007040440
Baudoin P, Provoost AP. Effects of age at the time of unilateral nephrectomy and dietary protein on long-term renal function in rats. Pediatric Nephrology. 1993; 7(5): 536–542p.
Schrier RW, Estacio RO, Esler A, Mehler P. Effects of Aggressive Blood Pressure Control in Normotensive Type 2 Diabetic Patients on Albuminuria, Retinopathy and Strokes. Kidney Int. 2002; 61(3): 1086–1097p. doi:10.1046/j.1523-1755.2002.00213.x
Altemose KE, Brady TM. Pediatric Hypertension. Curr Treat Options Pediatr. 2019; 5(2): 61–77p. doi:10.1007/s40746-019-00151-w
Jafar TH, Schmid CH, Landa M, et al. Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease. A Meta-Analysis of Patient-Level Data. Ann Intern Med. 2001; 135(2): 73–87p. doi:10.7326/0003-4819-135-2-200107170-00007
Izuhara Y, Nangaku M, Inagi R, et al. Renoprotective Properties of Angiotensin Receptor Blockers beyond Blood Pressure Lowering. J Am Soc Nephrol. 2005; 16(12): 3631–3641p. doi:10.1681/ASN.2005050522
Wilmer WA, Rovin BH, Hebert CJ, Rao SV, Kumor K, Hebert LA. Management of Glomerular Proteinuria: A Commentary. J Am Soc Nephrol. 2003; 14(12): 3217–3232p. doi:10.1097/01.ASN.0000100145.27188.33
Kumagai H, Hayashi K, Kumamaru H, et al. Amlodipine is Comparable to Angiotensin-Converting Enzyme Inhibitor for Long-Term Renoprotection in Hypertensive Patients with Renal Dysfunction: A One-Year, Prospective, Randomized Study. Am J Hypertens. 2000; 13(09): 980–985p.
Smidt UM, Andersen AR, et al. Early Aggressive Antihypertensive Treatment Reduces Rate of Decline in Kidney Function in Diabetic Nephropathy. Lancet. 1983;1(8335);1175-1179p.
Wright JT, Bakris G, Greene T, et al. Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease: Results from the AASK Trial. J Am Med Assoc. 2002; 288(19): 2421–2431p. doi:10.1001/jama.288.19.2421
Bakris GL, Fonseca V, Katholi RE, et al. Differential Effects of β-Blockers on Albuminuria in Patients with Type 2 Diabetes. Hypertension. 2005; 46(6): 1309–1315p. doi:10.116110.1161/01.HYP.0000190585.54734.48
Wühl E, Hadtstein C, Mehls O, Schaefer F. Home, Clinic, and Ambulatory Blood Pressure Monitoring in Children with Chronic Renal Failure. Pediatr Res. 2004; 55(3): 492–497p. doi: 10.1203/01.PDR.0000106863.90996.76
Newman R. For Personal Use. Only Reproduce with Permission from The Lancet Publishing Group. 2003; 361: 2003.
Fouque D, Laville M. Low Protein Diets for Chronic Kidney Disease in Non Diabetic Adults. Cochrane Database Syst Rev. 2009; (3): CD001892p. doi:10.1002/14651858.CD001892.pub3
Levey AS, Greene T, Sarnak MJ, et al. Effect of Dietary Protein Restriction on the Progression of Kidney Disease: Long-Term Follow-Up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis. 2006; 48(6): 879–888p. doi:10.1053/j.ajkd.2006.08.023
Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J. The Effect of Fluvastatin on Cardiac Outcomes in Patients with Moderate to Severe Renal Insufficiency: A Pooled Analysis of Double-Blind, Randomized Trials. Int J Cardiol. 2007; 117(1): 64–74p. doi:10.1016/j.ijcard. 2006.06.003
Epstein M, Campese VM. Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors on Renal Function. Am J Kidney Dis. 2005; 45(1): 2–14p. doi:10.1053/j.ajkd.2004.08.040
Wühl E, Trivelli A, Picca S, et al. Strict Blood-Pressure Control and Progression of Renal Failure in Children. N Engl J Med. 2009; 361(17): 1639–1650p. doi:10.1056/NEJMoa0902066
Zoja C, Corna D, Rottoli D, et al. Effect of Combining ACE Inhibitor and Statin in Severe Experimental Nephropathy. Kidney Int. 2002; 61(5): 1635–1645p. doi:10.1046/j.1523-1755.2002.00332.x
Matteucci MC, Wühl E, Picca S, et al. Left Ventricular Geometry in Children with Mild to Moderate Chronic Renal Insufficiency. J Am Soc Nephrol. 2006; 17(1): 218–226p. doi:10.1681/ ASN.2005030276
Rettig RA, Norris K, Nissenson AR. Chronic Kidney Disease in the United States: A Public Policy Imperative. Clin J Am Soc Nephrol. 2008; 3(6): 1902–1910p. doi:10.2215/CJN.02330508
Dwivedi D, Pandey AK, et al. Management of Chronic Kidney Disease through Ayurveda: A Case Study. World J Pharm Pharm Sci. 2017; 6(2): 1318–1325p.
Lam KSL, Cheng IKP, Janus ED, Pang RWC. Cholesterol-Lowering Therapy may Retard the Progression of Diabetic Nephropathy. Diabetologia. 1995; 38(5): 604–609p. doi:10.1007/ BF00400731
Refbacks
- There are currently no refbacks.
Copyright (c) 2020 Research and Reviews: A Journal of Pharmaceutical Science